Fidelity Disruptive Medicine ETF FMED
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.50%
- Net assets
- $41.0M
- Holdings
- 70
- 12-month distribution yield
- Unavailable
- Asset class
- Equity
Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Fidelity. Its category is Equity · Global (equity). Its last price was US$31.80 on 20 Oct 2026. Its expense ratio is 0.5% a year, from its prospectus dated 24 Sep 2025. It reported net assets of US$40.98 million as of 31 May 2026. Its latest holdings report lists 70 holdings as of 31 May 2026. No distributions are recorded for it over the last 12 months.
Fees
- Total annual operating expenses (gross)
- 0.50%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.50%
- Prospectus date
- Not stated
- Filed with the SEC
- 24 Sep 2025
Size and reporting
- Net assets
- $40,976,397
- Total assets
- $45,202,711
- Holdings as of
- 31 May 2026
- Report made public
- 24 Jul 2026 (54 days after the month end)
Top holdings
Largest 25 of 70 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Fidelity Revere Street Trust Fidelity Securities Lending Cash Central Fund | US31635A3032 | 10.27% | $4.2M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | UCB SA | BE0003739530 | 4.73% | $1.9M | Equity (common) | Belgium | EUR |
| 3 | LIFESTANCE HEALTH GROUP INC | US53228F1012 | 4.27% | $1.8M | Equity (common) | United States | USD |
| 4 | DANAHER CORP | US2358511028 | 3.42% | $1.4M | Equity (common) | United States | USD |
| 5 | 10X GENOMICS INC | US88025U1097 | 3.11% | $1.3M | Equity (common) | United States | USD |
| 6 | INTUITIVE SURGICAL INC | US46120E6023 | 2.92% | $1.2M | Equity (common) | United States | USD |
| 7 | COGENT BIOSCIENCES INC | US19240Q2012 | 2.85% | $1.2M | Equity (common) | United States | USD |
| 8 | ALNYLAM PHARMACEUTICALS INC | US02043Q1076 | 2.79% | $1.1M | Equity (common) | United States | USD |
| 9 | ARGENX SE ARGENX SE SPONSORED ADR | US04016X1019 | 2.78% | $1.1M | Equity (common) | Netherlands | USD |
| 10 | LEGEND BIOTECH CORP LEGEND BIOTECH CORP SPON ADR | US52490G1022 | 2.29% | $940K | Equity (common) | Cayman Islands | USD |
| 11 | UNITEDHEALTH GROUP INC | US91324P1021 | 2.25% | $922K | Equity (common) | United States | USD |
| 12 | BIO TECHNE CORP | US09073M1045 | 2.24% | $919K | Equity (common) | United States | USD |
| 13 | ASCENDIS PHARMA A/S | DK0060615755 | 2.11% | $866K | Equity (common) | Denmark | USD |
| 14 | EDWARDS LIFESCIENCES CORP | US28176E1082 | 2.11% | $865K | Equity (common) | United States | USD |
| 15 | MODERNA INC | US60770K1079 | 2.11% | $863K | Equity (common) | United States | USD |
| 16 | KYMERA THERAPEUTICS INC | US5015751044 | 1.99% | $814K | Equity (common) | United States | USD |
| 17 | XENON PHARMACEUTICALS INC | CA98420N1050 | 1.92% | $786K | Equity (common) | Canada | USD |
| 18 | HEARTFLOW INC | US42238D1072 | 1.89% | $774K | Equity (common) | United States | USD |
| 19 | SARTORIUS STEDIM BIOTECH | FR0013154002 | 1.84% | $755K | Equity (common) | France | EUR |
| 20 | INSMED INC | US4576693075 | 1.79% | $735K | Equity (common) | United States | USD |
| 21 | VEEVA SYS INC VEEVA SYS INC CL A | US9224751084 | 1.78% | $730K | Equity (common) | United States | USD |
| 22 | VAXCYTE INC | US92243G1085 | 1.77% | $723K | Equity (common) | United States | USD |
| 23 | REVOLUTION MEDICINES INC | US76155X1000 | 1.73% | $709K | Equity (common) | United States | USD |
| 24 | CARIS LIFE SCIENCES INC | US1421521071 | 1.71% | $702K | Equity (common) | United States | USD |
| 25 | CRINETICS PHARMACEUTICALS INC | US22663K1079 | 1.65% | $675K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.73% | |
| Short-term investment vehicles (cash funds) | 10.56% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 88.17% | |
| Belgium | 4.73% | |
| Netherlands | 3.70% | |
| Cayman Islands | 3.40% | |
| Denmark | 2.11% | |
| Canada | 1.92% | |
| France | 1.84% | |
| Bermuda | 1.78% | |
| United Kingdom | 1.42% | |
| Switzerland | 1.22% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 102.49% | |
| Euro (EUR) | 6.57% | |
| Swiss franc (CHF) | 1.22% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 51.32% | |
| Industrials | 4.96% | |
| Health Technology | 2.86% | |
| Technology | 2.76% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- Unavailable
- 12-month yield
- Unavailable
- Frequency
- None in 12 months
- Latest ex-date
- 20 Dec 2024
12-month yield = distributions per unit with an ex-date in the last 12 months ÷ latest price × 100. It is not shown because there were no distributions in the last 12 months.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (2 payments)
| Ex-date | Amount per unit |
|---|---|
| 20 Dec 2024 | $0.1120 |
| 21 Jun 2024 | $0.0010 |
Filings and sources
- Form N-PORT report for May 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000079688) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- FMED and VT Vanguard Total World Stock Index ETF
- FMED and SMH VanEck Semiconductor ETF
- FMED and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- FMED and CGDV Capital Group Dividend Value ETF